RecallDepth
Class II Ongoing

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
November 17, 2025
Posted
December 24, 2025
Recall Number
D-0239-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
575 1x10 Foil Blister Packs
Firm Location
Anaheim, CA, United States

Reason for Recall

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Distribution

Natinowide in the USA

Lot / Code Info

Lot: J1325J, I1725P, EXP Date: 4/30/2027.

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls